Michael Zinda - 04 Mar 2025 Form 4 Insider Report for Repare Therapeutics Inc. (RPTX)

Role: EVP, CHIEF SCIENTIFIC OFFICER
Signature: /s/ Steve Forte, Attorney-in-Fact
Issuer symbol: RPTX
Transactions as of: 04 Mar 2025
Net transactions value: $0
Form type: 4
Filing time: 06 Mar 2025, 17:00:09 UTC
Previous filing: 01 Apr 2024
Next filing: 14 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RPTX	Common Shares	Award	$0	+14,000	+19%	$0.000000	85,908	04 Mar 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	RPTX	Employee Stock Option (right to buy)	Award	$0	+75,000		$0.000000	75,000	04 Mar 2025	Common Shares	75,000	$1.17	Direct	F2
transaction	RPTX	Employee Stock Option (right to buy)	Award	$0	+85,000		$0.000000	85,000	04 Mar 2025	Common Shares	85,000	$1.17	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit ("RSU") award. Thirty-three and one third percent (33 1/3%) of the RSUs shall vest on each of March 4, 2026, March 4, 2027 and March 4, 2028, subject to Reporting Person continuing to provide service through each such date.
F2	The option will vest in in full on March 4, 2026, subject to Reporting Person continuing to provide service through such date.
F3	Twenty-five percent (25%) of the shares subject to the option shall vest on March 4, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to Reporting Person continuing to provide service through each such date.